Literature DB >> 25463360

Ten-year (2002-2012) cardiovascular disease incidence and all-cause mortality, in urban Greek population: the ATTICA Study.

Demosthenes B Panagiotakos1, Ekavi N Georgousopoulou2, Christos Pitsavos3, Christina Chrysohoou3, Vassiliki Metaxa3, Georgios A Georgiopoulos3, Katerina Kalogeropoulou2, Dimitris Tousoulis3, Christodoulos Stefanadis3.   

Abstract

AIM: The 10-year incidence of cardiovascular disease (CVD) and all-cause mortality, as well as its determinants, in a sample of men and women from Greece, was evaluated.
METHODS: From May 2001 to December 2002, 1514 men and 1528 women (>18y) without any clinical evidence of CVD or any other chronic disease, at baseline, living in greater Athens area, in Greece, were enrolled. In 2011-12, the 10-year follow-up was performed in 2583 participants (15% of the participants were lost to follow-up). Incidence of fatal or non-fatal CVD (coronary heart disease, acute coronary syndromes, stroke, or other CVD) was defined according to World Health Organization (WHO)-International Coding Diseases (ICD)-10 criteria.
RESULTS: The 10-year CVD incidence was 19.7% in men and 11.7% in women (p<0.001). Multi-adjusted analysis revealed that the determinants of CVD events were increased age (Hazard ratio (HR) per year=1.06, 95%Confidence Interval (CI): 1.04, 1.08), male sex (HR=1.40, 95%CI: 0.90, 2.19), smoking (HR=1.53, 95%CI: 1.03, 2.27), C-reactive protein levels (HR per 1mg/L=1.06, 95%CI: 1.02, 1.15), as well as adherence to Mediterranean diet (protective) (HR per 1/55 units=0.98, 95%CI: 0.95, 1.01).
CONCLUSION: The burden of CVD and its related risk factors is at emerging rates, in Greece, making the need for effective public health actions, more necessary than ever before.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Epidemiology; Greece; Incidence; Prevention

Mesh:

Year:  2014        PMID: 25463360     DOI: 10.1016/j.ijcard.2014.11.206

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  35 in total

1.  Association between Siesta (Daytime Sleep), Dietary Patterns and the Presence of Metabolic Syndrome in Elderly Living in Mediterranean Area (Medis Study): The Moderating Effect of Gender.

Authors:  E N Georgousopoulou; N Naumovski; D D Mellor; S Tyrovolas; S Piscopo; G Valacchi; N Tsakountakis; A Zeimbekis; V Bountziouka; E Gotsis; G Metallinos; D Tyrovola; J Kellett; A Foscolou; J-A Tur; A-L Matalas; C Lionis; E Polychronopoulos; L Sidossis; D Panagiotakos
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

2.  Stage 1 hypertension, but not elevated blood pressure, predicts 10-year fatal and non-fatal CVD events in healthy adults: the ATTICA Study.

Authors:  Elena Critselis; Christina Chrysohoou; Natasa Kollia; Ekavi N Georgousopoulou; Dimitrios Tousoulis; Christos Pitsavos; Demosthenes B Panagiotakos
Journal:  J Hum Hypertens       Date:  2019-02-11       Impact factor: 3.012

3.  Exploring attitudes towards endocrine diseases in Greece.

Authors:  Vaitsa Giannouli; Nikolaos Syrmos
Journal:  Endocrine       Date:  2016-11-07       Impact factor: 3.633

4.  Reply to Letter to the Editor to J-shaped relationship between habitual coffee consumption and 10-year (2002-2012) cardiovascular disease incidence: the ATTICA study.

Authors:  Georgia-Maria Kouli; Demosthenes B Panagiotakos; Ekavi N Georgousopoulou; Duane D Mellor; Christina Chrysohoou; Adela Zana; Constantine Tsigos; Dimitrios Tousoulis; Christodoulos Stefanadis; Christos Pitsavos
Journal:  Eur J Nutr       Date:  2017-09       Impact factor: 5.614

5.  Mediterranean lifestyle and cardiovascular disease prevention.

Authors:  Ekavi N Georgousopoulou; Duane D Mellor; Nenad Naumovski; Evangelos Polychronopoulos; Stefanos Tyrovolas; Suzanne Piscopo; Giuseppe Valacchi; Foteini Anastasiou; Akis Zeimbekis; Vassiliki Bountziouka; Efthimios Gotsis; George Metallinos; Dimitra Tyrovola; Alexandra Foscolou; Josep-Antoni Tur; Antonia-Leda Matalas; Christos Lionis; Labros Sidossis; Demosthenes Panagiotakos
Journal:  Cardiovasc Diagn Ther       Date:  2017-04

6.  J-shaped relationship between habitual coffee consumption and 10-year (2002-2012) cardiovascular disease incidence: the ATTICA study.

Authors:  Georgia-Maria Kouli; Demosthenes B Panagiotakos; Ekavi N Georgousopoulou; Duane D Mellor; Christina Chrysohoou; Adela Zana; Constantine Tsigos; Dimitrios Tousoulis; Christodoulos Stefanadis; Christos Pitsavos
Journal:  Eur J Nutr       Date:  2017-04-19       Impact factor: 5.614

7.  The association of protein and carbohydrate intake with successful aging: a combined analysis of two epidemiological studies.

Authors:  Alexandra Foscolou; Emmanuela Magriplis; Stefanos Tyrovolas; Christina Chrysohoou; Labros Sidossis; Antonia-Leda Matalas; Loukianos Rallidis; Demosthenes Panagiotakos
Journal:  Eur J Nutr       Date:  2018-04-23       Impact factor: 5.614

8.  Association of Socio-Environmental Determinants with Diabetes Prevalence in the Athens Metropolitan Area, Greece: A Spatial Analysis.

Authors:  Antigoni Faka; Christos Chalkias; Diego Montano; Ekavi N Georgousopoulou; Anestis Tripitsidis; Efi Koloverou; Dimitris Tousoulis; Christos Pitsavos; Demosthenes B Panagiotakos
Journal:  Rev Diabet Stud       Date:  2018-03-10

Review 9.  The effects of the Mediterranean diet on rheumatoid arthritis prevention and treatment: a systematic review of human prospective studies.

Authors:  Casuarina Forsyth; Matina Kouvari; Nathan M D'Cunha; Ekavi N Georgousopoulou; Demosthenes B Panagiotakos; Duane D Mellor; Jane Kellett; Nenad Naumovski
Journal:  Rheumatol Int       Date:  2017-12-18       Impact factor: 2.631

10.  Adiponectin circulating levels and 10-year (2002-2012) cardiovascular disease incidence: the ATTICA Study.

Authors:  Ioannis Kyrou; Olga Tsantarlioti; Demosthenes B Panagiotakos; Constantine Tsigos; Ekavi Georgousopoulou; Christina Chrysohoou; Ioannis Skoumas; Dimitrios Tousoulis; Christodoulos Stefanadis; Christos Pitsavos
Journal:  Endocrine       Date:  2017-10-16       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.